Enhanced expression of ten‐eleven translocation 1 reverses gemcitabine resistance in cholangiocarcinoma accompanied by a reduction in P‐glycoprotein expression
Abstract Increasing evidence revealed that ten‐eleven translocation 1 (TET1) plays an important role in tumorigenesis and chemoresistance, but its functions in gemcitabine resistance in cholangiocarcinoma (CCA) remain unknown. This study aims to investigate the effect of TET1 on gemcitabine resistan...
Saved in:
Main Authors: | Chuanxu Wang, Hua Ye, Lei Zhang, Yayu Cheng, Shifeng Xu, Ping Zhang, Zijie Zhang, Jimin Bai, Fangkang Meng, Lin Zhong, Guangjun Shi, Hao Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.1983 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gemcitabine combined with baicalein exerts antiviral activity against PEDV by inhibiting the entry and replication phases
by: Yingge Zheng, et al.
Published: (2025-02-01) -
Conversion therapy for unresectable intrahepatic cholangiocarcinoma using gemcitabine plus S-1 combined with PD-1 inhibitors: a case report
by: Shuangying Zhao, et al.
Published: (2025-01-01) -
Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
by: MENG Zihe, et al.
Published: (2025-01-01) -
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
by: REN Jiaqiang, et al.
Published: (2024-12-01) -
Solubility of gemcitabine (an anticancer drug) in supercritical carbon dioxide green solvent: Experimental measurement and thermodynamic modeling
by: Gholamhossein Sodeifian, et al.
Published: (2025-02-01)